By Russ Britt, MarketWatch
(Editor's note: Updated to show Chimerix drug used on Ebola patient.)
LOS ANGELES (MarketWatch) -- The number of companies with a hand in trying to find an effective combatant against the deadly Ebola virus is growing almost as quickly as the disease spreads, and one player's drug was used to treat the Texas man stricken with the malady shortly after receiving regulatory approval on Monday
The U.S. Food and Drug Administration has authorized a drug developed by Chimerix Inc. (CMRX) for use as an emergency investigational new treatment in the rapid deployment against Ebola.
for UPDATE: Number of companies fighting Ebola grows, one wins fed OK investment picks